inTEST Corporation
AMEX:INTTSemiconductors
+$0.85 today
- Market cap
- $159.43M
- Beta
- 1.48
- P/E (TTM)
- 386.0
- EPS (TTM)
- $0.05
Volume 0.14M
Average 0.32M
INTT Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
inTEST CorporationAMEX: INTT
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $644K (cash outflow) rose 181.2% year over year, ahead of the +68.8% change in trailing-twelve-month capital expenditures. Sequentially, it rose 20.6% from the prior quarter. Over 3 fiscal years it compounded at +6.1% a year.
Context
- Capital expenditures amounted to 1.4% of revenue in FY2025, up 0.4 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +181.2% holds above the trailing-twelve-month pace of +68.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (1.63M) USD
- Year-over-year change
- -23.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.63M) | -23.3% |
| FY2024 | 2024-12-31 | (1.32M) | -2.6% |
| FY2023 | 2023-12-31 | (1.29M) | +5.4% |
| FY2022 | 2022-12-31 | (1.37M) | -37.3% |
| FY2021 | 2021-12-31 | (994K) | — |
Capital Expenditures vs competitors
How INTT compares with its peers on the latest reported figures
- INTT's LTM Mar 2026 capital expenditures of $2.05M is the 8th largest of the 11 companies compared; the peer median is $7M.
- Its year-over-year change of +68.8% is the 2nd highest of 10, against a peer median of -16.3%.
- Capital expenditures amounts to 1.7% of revenue for INTT, versus a peer median of 2.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $265.02M | +18.5% | +11.1% | 5.9% | |
| LTM Sep 2026 | $55.4M | -3.7% | -20.5% | 2.3% | |
| LTM Sep 2026 | $16.41M | -9.3% | -9.7% | 2.3% | |
| LTM Jul 2026 | $13.99M | -16.3% | -9.2% | 1.5% | |
| LTM Jun 2026 | $11.66M | -38.3% | +12.4% | 2.2% | |
| LTM Sep 2026 | $2.34M | -82.9% | +1.9% | 0.3% | |
| LTM May 2026 | $2.07M | -58.6% | +14.9% | 4.1% | |
| LTM Mar 2026 | $2.05M | +68.8% | +6.1% | 1.7% | |
| LTM Mar 2026 | $1.43M | +92.6% | -13.0% | 2.5% | |
| LTM Mar 2026 | $1.27M | -58.3% | -5.8% | 1.6% | |
| LTM Jun 2026 | $0 | — | +20.7% | 0.0% | |
| Peer median (excluding INTT) | $7M | -16.3% | -1.9% | 2.2% | |
Competitors are the stored peer set for INTT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.28M | 8.46M | 9.34M | 2.89M | (2.53M) |
| Depreciation & Amortization | 3.15M | 4.73M | 4.68M | 5.39M | 6.8M |
| Deferred Income Tax | (489K) | (1.66M) | (1.16M) | (1.51M) | (1.03M) |
| Stock-Based Compensation | 1.45M | 1.79M | 2.05M | 1.86M | 1.61M |
| Change in Working Capital | (987K) | (15.7M) | 838K | (5.81M) | 1.99M |
| Accounts Receivables | (4.78M) | (4.89M) | 2.99M | (5.51M) | 4.53M |
| Inventory | (2.54M) | (10.63M) | 2.03M | 4.9M | (4.17M) |
| Accounts Payables | 1.18M | 2.88M | (1.81M) | (2.31M) | 3.15M |
| Other Working Capital | 5.16M | (3.05M) | (2.37M) | (2.9M) | (1.52M) |
| Other Non-Cash Items | 440K | 984K | 450K | 998K | 474K |
| Operating Cash Flow | 10.84M | (1.39M) | 16.2M | 3.82M | 7.32M |
| Capital Expenditures | (994K) | (1.37M) | (1.29M) | (1.32M) | (1.63M) |
| Acquisitions (Net) | (20.38M) | (179K) | 0 | (18.73M) | 0 |
| Purchases of Investments | 0 | (3.49M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 3.49M | 0 | 0 | 0 |
| Other Investing Activities | 0 | 371K | 0 | 0 | 0 |
| Investing Cash Flow | (21.37M) | (1.17M) | (1.29M) | (20.05M) | (1.63M) |
| Debt Repayment | 20.1M | (3.96M) | (4.1M) | (7.84M) | (8.35M) |
| Common Stock Issued | 0 | 0 | 19.24M | 283K | 146K |
| Common Stock Repurchased | 0 | 0 | 0 | (1.04M) | (17K) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.63M | 225K | 465K | (41K) | (17K) |
| Financing Cash Flow | 21.73M | (3.73M) | 15.61M | (8.64M) | (8.23M) |
| Effect of Forex Changes | (277K) | (324K) | 163K | (559K) | 770K |
| Net Change in Cash | 10.92M | (6.62M) | 30.68M | (25.43M) | (1.77M) |
| Free Cash Flow | 9.85M | (2.75M) | 14.91M | 2.5M | 5.68M |
inTEST Corporation
AMEX:INTT
Intrinsic Alpha fair value
Locked
Current Price
$12.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.